Home・Aandelen Lijst・Pulmatrix Inc

Pulmatrix Inc

Gesloten

1.39 -0.71

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

1.4

Max

1.43

Belangrijke statistieken
By Trading Economics
Inkomsten	136K -1M
EPS	-0.29
Werknemers	2
EBITDA	126K -1M

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-329K 5.4M
Vorige openingsprijs	2.1
Vorige sluitingsprijs	1.39

Pulmatrix Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

11 okt 2026, 23:51 UTC

China's Inflation Rate YoY for September 2026 set to release on October 14, with expectations of a slight increase to 0.1%, amid cautious market sentiment influenced by global economic factors and U.S. Treasury yields.

11 okt 2026, 23:51 UTC

China's PPI data release on October 14, 2026, expected to show a year-on-year increase of 4.5%, amid cautious optimism and potential implications for global inflation and monetary policy.

11 okt 2026, 23:51 UTC

China's inflation rate expected to rise by 0.3% MoM amid cautious market sentiment and global economic pressures ahead of key CPI reports.

11 okt 2026, 23:41 UTC

U.S. Import Prices Report on October 16 Forecasts 0.7% Increase Amid Cautious Market Sentiment and Geopolitical Tensions

11 okt 2026, 23:41 UTC

U.S. Export Prices Expected to Rise 0.01% in September Amid Mixed Economic Sentiment and Cautious Market Optimism

11 okt 2026, 23:31 UTC

Canada's Housing Starts Data Release on October 16 Forecasts Decline to 237.5K Units Amid Cautious Market Sentiment

11 okt 2026, 23:21 UTC

Core Producer Price Index (PPI) for September 2026 set to release on October 15, with a forecasted increase of 0.3%, amid mixed economic sentiment and rising Treasury yields impacting investor optimism.

11 okt 2026, 23:21 UTC

Market Braces for September PPI Release Amid Rising Treasury Yields and Fed Rate Hike Speculation

11 okt 2026, 23:21 UTC

Market Awaits Philadelphia Fed Manufacturing Index Release Amid Mixed Economic Sentiment and Caution Over Inflationary Pressures.

11 okt 2026, 23:21 UTC

Investors Brace for NY Empire State Manufacturing Index Release Amid High Treasury Yields and Inflation Concerns on October 15, 2026.

11 okt 2026, 23:11 UTC

Australia's Full-Time Employment Change Data Set for Release on October 15, Anticipated to Reflect Economic Resilience Amid Global Challenges.

11 okt 2026, 23:11 UTC

Australia's September 2026 unemployment rate forecasted to rise to 4.6%, raising market concerns ahead of the October release amid global economic volatility.

11 okt 2026, 23:11 UTC

Australia's Employment Change Report on October 15 Expected to Show Job Growth Amid Positive Labor Market Sentiment, but Analysts Warn of Potential Volatility.

11 okt 2026, 23:01 UTC

Investors Brace for Volatility Ahead of October 14 CPI Release Amid Rising Inflation Concerns and Fed Rate Hike Speculations.

11 okt 2026, 23:01 UTC

Core Inflation Rate for September 2026 set to rise by 0.2%, influencing market sentiment and Federal Reserve rate hike expectations ahead of key CPI reports.

11 okt 2026, 23:01 UTC

U.S. CPI Expected to Rise to 336.67 Amid Inflation Concerns and Market Volatility Ahead of October Release

11 okt 2026, 23:01 UTC

Core Inflation Rate YoY for September 2026 set to rise slightly to 2.5%, as markets brace for potential Federal Reserve interest rate hikes amid geopolitical tensions and high Treasury yields.

11 okt 2026, 23:01 UTC

Investors Brace for U.S. CPI Release on October 14, Anticipating Inflation Rise to 3.7% and Potential Fed Policy Shifts

11 okt 2026, 23:01 UTC

U.S. Inflation Rate Expected to Rise 0.6% in September Amidst Market Caution and High Treasury Yields Ahead of Federal Reserve Decisions

11 okt 2026, 23:01 UTC

Macro News

Gold prices are declining amid escalating geopolitical tensions and rising U.S. Treasury yields, remaining below its 20-day moving average.

11 okt 2026, 23:01 UTC

The EUR/NOK is advancing in early trading, influenced by geopolitical tensions and rising yields.

11 okt 2026, 23:01 UTC

The EUR/SEK is trading higher in early trading, rebounding after a slight dip amid rising yields and geopolitical tensions affecting market sentiment.

11 okt 2026, 22:51 UTC

Brazil's Retail Sales MoM data for August 2026, expected to rise by 0.8%, set for release on October 15 amid cautious economic sentiment influenced by global trends.

11 okt 2026, 22:31 UTC

Japan's Machinery Orders MoM data set for October 14, with a modest growth forecast of 0.03% amid cautious market sentiment following recent volatility.

11 okt 2026, 22:31 UTC

RBA Meeting Minutes on October 13 Expected to Address Inflation Concerns and Future Monetary Policy Adjustments.

11 okt 2026, 22:31 UTC

Australia's NAB Business Confidence Report Set for Release Amidst Cautious Market Sentiment and Ongoing Economic Challenges

11 okt 2026, 22:21 UTC

Singapore's Q3 2026 GDP Growth Rate Expected at 0.9%, Amid Cautious Optimism and Input Cost Concerns

11 okt 2026, 22:21 UTC

Mortgage Rates Hit 7.49% Amid Rising Treasury Yields and Inflation Concerns, Sparking Caution in Housing Market Ahead of Upcoming Data Release

11 okt 2026, 22:11 UTC

Brazil's Central Bank to Provide Key Interest Rate Insights Amid Political Turmoil on October 13, 2026.

11 okt 2026, 22:01 UTC

South Korea's September 2026 unemployment rate release on October 15 expected to reveal job market stability amid global inflation concerns.

Peer Vergelijking

Prijswijziging

Pulmatrix Inc Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

Buy

Hold

Sell

Gebaseerd op 0 analisten die aandelenratings hebben gegeven aan Pulmatrix Inc - Dist in de afgelopen 3 maanden.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Pulmatrix Inc

Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates. The company was founded in 2003 and is headquartered in Bedford, Massachusetts.